Valuation: Photocure ASA

Market Cap 1.4B 148M 128M 120M 110M 206M 14.12B 209M 1.41B 552M 7.07B 556M 544M 23.57B P/E 2026 *
18.4x
P/E 2027 * 66.8x
Enterprise Value 1.23B 130M 113M 106M 96.4M 181M 12.42B 184M 1.24B 486M 6.22B 489M 478M 20.73B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.87x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+1.15%
1 week+4.15%
Current month-0.57%
1 month-10.68%
3 months-16.48%
6 months-16.61%
Current year-26.19%
1 week 50.5
Extreme 50.5
53.5
1 month 46.25
Extreme 46.25
60
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 31/10/2018
Chief Tech/Sci/R&D Officer - 31/07/2021
Human Resources Officer - 31/01/2021
Director TitleAgeSince
Director/Board Member - 31/12/2021
Chairman - 26/09/2023
Director/Board Member - 22/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.15%+4.15%-13.75%+21.29% 148M
+0.70%+4.59%+91.35%+127.43% 1,083B
+0.36%+1.40%+51.17%+50.59% 626B
-0.36%+1.16%+25.38%+63.56% 442B
-0.92%+0.22%+48.34%+38.00% 363B
-1.32%-0.21%+29.07%+36.60% 295B
-1.20%-2.78%+5.56%+5.29% 248B
+0.25%+2.18%+46.23%+59.69% 224B
-2.51%+1.77%-6.55%-51.64% 210B
-1.05%+3.34%+13.44%+70.51% 168B
Average -0.58%+3.42%+29.02%+42.13% 365.93B
Weighted average by Cap. -0.38%+4.29%+49.44%+65.06%

Financials

2026 *2027 *
Net sales 658M 69.5M 60.21M 56.41M 51.46M 96.74M 6.63B 98.22M 664M 259M 3.32B 261M 255M 11.07B 666M 70.34M 60.94M 57.1M 52.08M 97.91M 6.71B 99.42M 672M 263M 3.36B 264M 258M 11.2B
Net income 76.33M 8.06M 6.98M 6.54M 5.97M 11.22M 769M 11.39M 76.93M 30.07M 385M 30.25M 29.6M 1.28B 21M 2.22M 1.92M 1.8M 1.64M 3.09M 211M 3.13M 21.17M 8.27M 106M 8.32M 8.14M 353M
Net Debt -169M -17.84M -15.46M -14.48M -13.21M -24.83M -1.7B -25.22M -170M -66.58M -852M -66.98M -65.53M -2.84B -157M -16.57M -14.36M -13.45M -12.27M -23.07M -1.58B -23.42M -158M -61.85M -791M -62.23M -60.87M -2.64B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
12/08/26 NOK 52.70 +1.15% 40,740
11/08/26 NOK 52.10 -0.95% 34,469
10/08/26 NOK 52.60 +2.14% 45,311
07/08/26 NOK 51.50 +0.19% 80,550
06/08/26 NOK 51.40 +1.58% 80,356
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
52.10NOK
Average target price
79.67NOK
Spread / Average Target
+52.91%

Quarterly revenue - Rate of surprise